Bausch + Lomb Corporation (BLCO)
NYSE: BLCO
· Real-Time Price · USD
11.35
-0.21 (-1.82%)
At close: May 01, 2025, 11:46 AM
-1.82% (1D)
| Bid | 11.3 |
| Market Cap | 4.01B |
| Revenue (ttm) | 4.83B |
| Net Income (ttm) | -490M |
| EPS (ttm) | -0.9 |
| PE Ratio (ttm) | -12.61 |
| Forward PE | 12.85 |
| Analyst | Hold |
| Ask | 11.39 |
| Volume | 675,752 |
| Avg. Volume (20D) | 800,259 |
| Open | 11.61 |
| Previous Close | 11.56 |
| Day's Range | 11.22 - 11.77 |
| 52-Week Range | 10.45 - 21.69 |
| Beta | 0.54 |
About BLCO
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date May 6, 2022
Employees 13,500
Stock Exchange NYSE
Ticker Symbol BLCO
Website https://www.bausch.com
Analyst Forecast
According to 11 analyst ratings, the average rating for BLCO stock is "Hold." The 12-month stock price forecast is $17.5, which is an increase of 54.19% from the latest price.
Stock ForecastsEarnings Surprise
Bausch + Lomb has released their quartely earnings
on Apr 30, 2025:
1 day ago
-15.74%
Bausch + Lomb shares are trading lower after the c...
Unlock content with
Pro Subscription
2 months ago
-9.52%
Bausch + Lomb shares are trading lower after the company announced that the process of going private will not result in a transaction at this time. Also, the company announced that the process to complete a full separation did not lead to an offer that reflected its value.
